Key facts
- It has raised $51.9M; the latest was Accelerator/Incubator in Jul 2025.
- Notable investors include Microsoft for Startups, Mucker Capital, Morgan Stanley Expansion Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Octagos
- ·The full record, as it builds
Funding rounds
No funding rounds for Octagos are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Octagos
Developer of a cardiac remote monitoring software designed to monitor and consolidate device transmissions and patient data in real-time. The company's software consolidates implantable and wearable data onto one platform, artificial intelligence is applied to the data to interpret complex cardiac data and then connected to EMR (electronic medical record) systems, enabling healthcare professionals to manage high volumes of patient data and identify what is urgent, so they do not miss anything critical.
- Sector
- Healthcare
- HQ
- Houston, TX, United States
- Founded
- 2020
- Employees
- 111
- Website
- octagos.com/
- Ownership
- Privately Held (backing)
Octagos doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Octagos shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Octagos in its N-PORT filings yet. We sweep new filings monthly.